HEPATIC ENCEPHALOPATHY
Clinical trials for HEPATIC ENCEPHALOPATHY explained in plain language.
Never miss a new study
Get alerted when new HEPATIC ENCEPHALOPATHY trials appear
Sign up with your email to follow new studies for HEPATIC ENCEPHALOPATHY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could a simple gut drug reverse liver confusion?
Disease control CompletedThis study tested whether nifuroxazide, a gut infection drug, can help reverse confusion caused by liver disease (hepatic encephalopathy) in 80 adults with cirrhosis. Participants had moderate to severe confusion and were treated in the hospital. The goal was to see if the drug c…
Matched conditions: HEPATIC ENCEPHALOPATHY
Phase: PHASE3 • Sponsor: Cairo University • Aim: Disease control
Last updated May 17, 2026 05:07 UTC
-
New sleep aid shows promise for liver patients
Symptom relief CompletedThis study tested a sleep medication called lemborexant in 82 adults with liver cirrhosis who had trouble sleeping. The goal was to see if the drug could improve sleep quality safely. The approach used a drug that works differently from common sleep aids to avoid liver-related ri…
Matched conditions: HEPATIC ENCEPHALOPATHY
Phase: PHASE2 • Sponsor: Indonesia University • Aim: Symptom relief
Last updated May 17, 2026 05:27 UTC